A new easy-to-use legal tool that enables exchange of biological material between research institutes and companies launches today.
Human genome editing, 3D-printed replacement organs and artificial photosynthesis – the field of bioengineering offers great promise for tackling the major challenges that face our society. But as a new article out today highlights, these developments provide both opportunities and risks in the short and long term.
A movement is under way that will fast-forward the design of new plant traits. It takes inspiration from engineering and the software industry, and is being underpinned in Cambridge and Norwich by an initiative called OpenPlant.
Inspired by the way open source data has stimulated innovation in computing, a new UK centre will create a climate of openness in synthetic biology, helping young researchers and entrepreneurs develop and share new tools and libraries of plant DNA.
Big Data, Cardiovascular Disease, Public Policy and Synthetic Biology: new Strategic Research Initiatives27 Nov 2013
Four new targets have been added to the University of Cambridge’s Strategic Research Initiative program, which fosters multi-disciplinary collaboration to advance innovative research.
A new method which streamlines the design and construction of synthetic membrane pores could improve a range of scientific processes, including speeding up the development of new drugs, and enabling more efficient disease diagnosis through DNA sequence detection.
Scientists discover highly asymmetric and branched patterns are the result of physical forces and local instabilities; research has important implications for understanding biofilms and multicellular systems.